Cell division captured with the X-Light V2

ADVANCING MICROSCOPY TO POWER DISCOVERY

CrestOptics S.p.A. is a leading company in the development and manufacturing of advanced systems for fluorescence microscopy. Thanks to our strength in R&D and engineering, we specialize in supporting the research community, biotech, and pharma industry with custom solutions tailored for ever-changing demands, paying special attention to customers’ needs and scientific applications.

Our story.

Founded in 2011 with a mission to make high-end microscopy technology accessible, we quickly achieved the necessary expertise to build top-tier systems that are indispensable for ground-breaking biological research. In November 2021 Apposite Capital, a specialist international healthcare and life science investor, acquired a majority shareholding in CrestOptics to partner with the management team and employees to accelerate market penetration globally and launch new products. Our products are supported globally by an experienced network of distributors of our branded products and integrated into prestigious and highly complex equipment, through OEM custom design or as a component.

Our purpose.

Through our commitment to excellence, we aim to drive technological innovation in microscopy and to contribute to the advancement of scientific knowledge in various fields, including life sciences, materials research, and biomedical imaging. We have recently taken a significant step towards a more sustainable future by prioritizing the creation of long-term economic, environmental, and social benefits for all stakeholders and generations to come. The application of ESG criteria in our organization’s business practices will generate significant value and impact for the scientific community.